Download Citation
Article Source:
Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
Sims JT,
Ganguly SS,
Bennett H,
Friend JW,
Tepe J,
et al.
(2013)
Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1.
PLOS ONE 8(1): e55509.
https://doi.org/10.1371/journal.pone.0055509